Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, and Efficacy of MZE782 in Adults With Phenylketonuria (PKU)

The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).

Phenylketonuria (PKU)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Maze TherapeuticsNCT07694440

A Multi-Center, Observational Study to Evaluate the Long-Term Safety of Subcutaneous Injections of Palynziq® (Pegvaliase) in Subjects With Phenylketonuria

This is a 10-year multi-center, global, observational study to further characterize the safety profile of pegvaliase, including hypersensitivity reactions, lon…

Phenylketonuria (PKU)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

BioMarin PharmaceuticalNCT05813678

Observational

Defining Protein Requirements in Adults With PKU: Impact of Genotype and Medical Food Intake

The objective of this research is to determine the protein requirements based on genotype and medical food consumption in a sample of adults with Phenylketonur…

PKU

Estimated

~$10 – $750

Actual pay is set by the research site.

Emory UniversityNCT07194993

Phase 3

An Open-Label Study to Evaluate the Long-Term Safety of JNT-517 in Participants With Phenylketonuria

The goal of this Phase 3, open-label study is to evaluate the long-term safety of JNT-517 in pediatric and adult participants with Phenylketonuria (PKU) after …

Phenylketonuria (PKU)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06628128

PheCheck™ Validation Study

The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sam…

Phenylketonuria (PKU) and Hyperphenylalaninemia

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Aptatek BioSciences, IncNCT07551921

A Multi-Center, Prospective, Longitudinal, Study Evaluating Immunologic, Inflammatory, and Laboratory Parameters Associated With Long-Term Palynziq® (Pegvaliase) Treatment in Subjects With Phenylketonuria (PKU) in the United States

This is a 10-year multi-center, prospective, longitudinal, single arm study evaluating immunologic, inflammatory and laboratory parameters associated with long…

Phenylketonuria (PKU)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

BioMarin PharmaceuticalNCT06305234